Pharmacokinetics of Trastuzumab in Haemodialysis

被引：6
|
作者：
Gori, Stefania [1 ]
Foglietta, Jennifer [2 ]
Lunardi, Gianluigi [1 ]
Inno, Alessandro [1 ]
Cardinali, Barbara [3 ]
Millo, Enrico [4 ,5 ]
Del Mastro, Lucia [3 ]
Nunzi, Emidio Giovanni [6 ]
Crino, Lucio [2 ]
机构：
[1] Osped Sacro Cuore Don Calabria, Dept Med Oncol, I-37024 Negrar Verona, Italy
[2] Azienda Osped Perugia, Dept Med Oncol, Perugia, Italy
[3] IRCCS AOU San Martino IST Natl Inst Canc Res, Dept Med Oncol, Dev Innovat Therapies Unit, Genoa, Italy
[4] Univ Genoa, Biochem Sect, Dept Expt Med DIMES, Genoa, Italy
[5] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy
[6] Azienda Osped Perugia, Unit Nephrol & Dialysis, Perugia, Italy
来源：
Breast Journal | 2015年 / 21卷 / 03期
关键词：
METASTATIC BREAST-CANCER; ANTI-HER2; MONOCLONAL-ANTIBODY; CHEMOTHERAPY;
D O I：
10.1111/tbj.12407
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：329 / 331
页数：3
相关论文
共 50 条
  • [21] Pharmacokinetics and administration method of gentamicin in a patient on haemodialysis
    Hiraki, Yoichi
    Hiraike, Mikako
    Nagano, Masahisa
    Ozono, Yukari
    Manabe, Kenichi
    Misumi, Nobuhiro
    Tsuji, Yasuhiro
    Kamimura, Hidetoshi
    Karube, Yoshiharu
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 44 (08) : 630 - 634
  • [22] Pharmacokinetics of amlodipine in hypertensive patients undergoing haemodialysis
    G. Kungys
    H. Naujoks
    C. Wanner
    European Journal of Clinical Pharmacology, 2003, 59 : 291 - 295
  • [23] Influence of continuous venovenous haemodialysis on midazolam pharmacokinetics
    Bolon, M.
    Bastien, O.
    Flamens, C.
    Paulus, S.
    Boulieu, R.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 114 - 114
  • [24] Pharmacokinetics and dosage adjustment of rifabutin in a haemodialysis patient
    Bassilios, N
    Launay-Vacher, V
    Hamani, AA
    Masias, L
    Peytavin, G
    Fau, JB
    Deray, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (03) : 531 - 532
  • [25] Effect of impaired renal function and haemodialysis on the pharmacokinetics of aprepitant
    Bergman, AJ
    Marbury, T
    Fosbinder, T
    Swan, S
    Hickey, L
    Bradstreet, TE
    Busillo, J
    Petty, KJ
    Aiyer, KJV
    Constanzer, M
    Huskey, SEW
    Majumdar, A
    CLINICAL PHARMACOKINETICS, 2005, 44 (06) : 637 - 647
  • [26] Pharmacokinetics of dabrafenib in a patient with metastatic melanoma undergoing haemodialysis
    Park, John J.
    Boddy, Alan V.
    Liu, Xiaoman
    Harris, David
    Lee, Vincent
    Kefford, Richard F.
    Carlino, Matteo S.
    PIGMENT CELL & MELANOMA RESEARCH, 2017, 30 (01) : 68 - 71
  • [27] Pharmacokinetics of nelfinavir during haemodialysis in a patient with HIV infection
    Armbruster, C
    Vorbach, H
    El Menyawi, I
    Meisl, FT
    Neumann, I
    AIDS, 2000, 14 (01) : 99 - 101
  • [28] Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis
    Sandri, Ana M.
    Landersdorfer, Cornelia B.
    Jacob, Jovan
    Boniatti, Marcio M.
    Dalarosa, Micheline G.
    Falci, Diego R.
    Behle, Taina F.
    Saitovitch, David
    Wang, Jiping
    Forrest, Alan
    Nation, Roger L.
    Zavascki, Alexandre P.
    Li, Jian
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (03) : 674 - 677
  • [29] Effect of Impaired Renal Function and Haemodialysis on the Pharmacokinetics of Aprepitant
    Arthur J. Bergman
    Thomas Marbury
    Trisha Fosbinder
    Suzanne Swan
    Lisa Hickey
    Thomas E. Bradstreet
    John Busillo
    Kevin J. Petty
    Kala-Jyoti Viswanathan Aiyer
    Marvin Constanzer
    Su-Er W. Huskey
    Anup Majumdar
    Clinical Pharmacokinetics, 2005, 44 : 637 - 647
  • [30] Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis
    Olav Spigset
    Staffan Hägg
    Bernd Stegmayr
    Rune Dahlqvist
    European Journal of Clinical Pharmacology, 2000, 56 : 699 - 703
12345